ArticleEnvironment international2020
How can airborne transmission of COVID-19 indoors be minimised?
Article in Environment international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 427 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
427 citing papers in PubMed, 5 syntheses or guidelines pooled it, 1,354 citations in OpenAlex.
- The impact of climate change on airborne and droplet-borne diseases and hospital response measures.Frontiers in public health · 2026Pooled it
- Contact dermatitis caused by prevention measures during the COVID-19 pandemic: a narrative review.Frontiers in public health · 2023Pooled it
- A review of strategies and their effectiveness in reducing indoor airborne transmission and improving indoor air quality.Environmental research · 2022Pooled it
- Long distance airborne transmission of SARS-CoV-2: rapid systematic review.BMJ (Clinical research ed.) · 2022Pooled it
- Transmission of COVID-19 and other infectious diseases in public washrooms: A systematic review.The Science of the total environment · 2022Pooled it
- Portable air cleaners and residential exposure to SARS-CoV-2 aerosols: A real-world study.Indoor air · 2022Trial
- Beyond Infection-Indoor Airborne Pathogens as Contributors to Respiratory Inflammation and Immune Dysregulation: A Narrative Review.Pathogens (Basel, Switzerland) · 2026Review
- A Method for Optimized Monitoring of Indoor Air Quality in Public Buildings.Sensors (Basel, Switzerland) · 2026Article
- Climatic Influence on COVID-19: Investigating the Role of Temperature and Humidity in the Spread of the Omicron Variant.GeoHealth · 2026Article
- Is There an Optimal Wavelength for Germicidal Ultraviolet Air Disinfection?Environmental science & technology · 2026Article
- Microbial innovations for sustainable construction: improving durability and environmental impact through the collaboration of civil engineering and microbiology.Archives of microbiology · 2026Review
- Indoor air quality and airborne transmission under the One Health lens: A scoping review.One health (Amsterdam, Netherlands) · 2025Review
- Household air pollution and health: rethinking indoor exposure in the places we call home.Scientific reports · 2025Article
- Fluid dynamical pathways of airborne transmission while waiting in a line.Science advances · 2025Article
- Associations between indoor air exposures and cognitive test scores among university students in classrooms with increased ventilation rates for COVID-19 risk management.Journal of exposure science & environmental epidemiology · 2025Article
- Occupational Transmission of Measles Despite COVID-19 Precautions.Pathogens (Basel, Switzerland) · 2025Article
- Capsid and genome damage are the leading inactivation mechanisms of aerosolized porcine respiratory coronavirus at different relative humidities.Applied and environmental microbiology · 2025Article
- A nationwide study of risk factors for long COVID and its economic and mental health consequences in the United States.Communications medicine · 2025Article
- SARS-CoV-2 dynamics in New York City during March 2020-August 2023.Communications medicine · 2025Article
- Need for a Holistic Approach to Assessing Sustainable, Green, and Healthy Buildings.Environment & health (Washington, D.C.) · 2025Review
367 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
36 authors at 20 institutions in 14 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
During the rapid rise in COVID-19 illnesses and deaths globally, and notwithstanding recommended precautions, questions are voiced about routes of transmission for this pandemic disease. Inhaling small airborne droplets is probable as a third route of infection, in addition to more widely recognized transmission via larger respiratory droplets and direct contact with infected people or contaminated surfaces. While uncertainties remain regarding the relative contributions of the different transmission pathways, we argue that existing evidence is sufficiently strong to warrant engineering controls targeting airborne transmission as part of an overall strategy to limit infection risk indoors. Appropriate building engineering controls include sufficient and effective ventilation, possibly enhanced by particle filtration and air disinfection, avoiding air recirculation and avoiding overcrowding. Often, such measures can be easily implemented and without much cost, but if only they are recognised as significant in contributing to infection control goals. We believe that the use of engineering controls in public buildings, including hospitals, shops, offices, schools, kindergartens, libraries, restaurants, cruise ships, elevators, conference rooms or public transport, in parallel with effective application of other controls (including isolation and quarantine, social distancing and hand hygiene), would be an additional important measure globally to reduce the likelihood of transmission and thereby protect healthcare workers, patients and the general public.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.